Safety and Efficacy
23
5
7
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
4.3%
1 terminated out of 23 trials
83.3%
-3.2% vs benchmark
22%
5 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (23)
RIG 101 Trial in Healthy Adults and Adults With Asthma
Study of T Cells Targeting CD19/BCMA (CART-19/BCMA) for High Risk Multiple Myeloma Followed With Auto-HSCT
Evaluation of Clinical, Perceived and Instrumental Efficacy of a Scar Gel in Preventing Hypertrophic Scars
Study on the Safety and Efficacy of MR-Linac Technique in Patients With Unresectable Locally Advanced Colon Cancer
A Clinical Study of the Safety and Efficacy of Chemogenetics Therapy in the Treatment of Parkinson's Disease
Safety and Efficacy of CD19 CAR-T/CAR-NK Cells
Safety and Analgesic Efficacy of a Modified Auriculotemporal Nerve Block
Study to Evaluate the Safety of a New Oxime, MMB4 DIMETHANESULFONATE (DMS)
Safety and Efficacy of SBRT in the Treatment of Thoracic Malignant Tumors at Different Sites
A Clinical Trial of Freeze-dried Human Rabies Vaccine (Vero Cells)
Vedolizumab, Anti-CD25 Antibody, Rapid Reduction of Glucocorticoids for SR-aGVHD With Gastrointestinal Involvement
NKG2D CAR-NK Cell Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Sintilimab in Combination With Chidamide in Refractory and Relapsed ENKTCL
Sintilimab in Combination With Chidamide in Newly Diagnosed ENKTCL
A Phase III Clinical Trial to Determine the Safety and Efficacy of ZF2001 for Prevention of COVID-19
Study of Chidamide for Steroid-resistant/Steroid-dependent Severe cGVHD
Plasma for Early Treatment in Non-hospitalised Mild or Moderate COVID-19 Patients
Basiliximab Combined With Ruxolitinib as Second-line Treatment of Grade 3-4 Steroid-resistant aGVHD
Induction Chemotherapy Sequential Sintilimab Combined With Dual Epigenetic Drugs for ENKTL-HLH
Clinical Study to Evaluate Safety and Efficacy of Amino Acid in Healthy Individuals